中国血吸虫病防治杂志
中國血吸蟲病防治雜誌
중국혈흡충병방치잡지
CHINESE JOURNAL OF SCHISTOSOMIASIS CONTROL
2015年
3期
319-320
,共2页
晚期血吸虫病%腹水型%临床路径
晚期血吸蟲病%腹水型%臨床路徑
만기혈흡충병%복수형%림상로경
Advanced schistosomiasis%Acites%Clinical pathway
目的：评价腹水型晚期血吸虫病（晚血）临床路径的救治效果。方法根据《血吸虫病防治手册》、《湖北省晚期血吸虫病临床路径》管理方案，分别采用传统路径和临床路径方法对洪湖市2013年和2014年各220例晚血患者进行治疗，比较患者平均住院日、疾病知晓率、患者满意度和平均费用等指标，分析临床路径管理在腹水型晚血病人治疗中的效果。结果采用临床路径治疗的患者在病情转归无明显差异的情况下，平均住院日由14 d下降到12 d，平均治疗费用由6400元下降到5800元，患者的疾病知晓率和满意度均提高到95%，与传统路径组相比，差异均具有统计学意义（P均<0.05）。结论采用临床路径治疗晚血能规范医疗行为，避免医疗资源的浪费，值得推广应用。
目的：評價腹水型晚期血吸蟲病（晚血）臨床路徑的救治效果。方法根據《血吸蟲病防治手冊》、《湖北省晚期血吸蟲病臨床路徑》管理方案，分彆採用傳統路徑和臨床路徑方法對洪湖市2013年和2014年各220例晚血患者進行治療，比較患者平均住院日、疾病知曉率、患者滿意度和平均費用等指標，分析臨床路徑管理在腹水型晚血病人治療中的效果。結果採用臨床路徑治療的患者在病情轉歸無明顯差異的情況下，平均住院日由14 d下降到12 d，平均治療費用由6400元下降到5800元，患者的疾病知曉率和滿意度均提高到95%，與傳統路徑組相比，差異均具有統計學意義（P均<0.05）。結論採用臨床路徑治療晚血能規範醫療行為，避免醫療資源的浪費，值得推廣應用。
목적：평개복수형만기혈흡충병（만혈）림상로경적구치효과。방법근거《혈흡충병방치수책》、《호북성만기혈흡충병림상로경》관리방안，분별채용전통로경화림상로경방법대홍호시2013년화2014년각220례만혈환자진행치료，비교환자평균주원일、질병지효솔、환자만의도화평균비용등지표，분석림상로경관리재복수형만혈병인치료중적효과。결과채용림상로경치료적환자재병정전귀무명현차이적정황하，평균주원일유14 d하강도12 d，평균치료비용유6400원하강도5800원，환자적질병지효솔화만의도균제고도95%，여전통로경조상비，차이균구유통계학의의（P균<0.05）。결론채용림상로경치료만혈능규범의료행위，피면의료자원적낭비，치득추엄응용。
Objective To evaluate the effect of the clinical pathway on advanced schistosomiasis patients with acites. Meth?ods According to the Handbook of Schistosomiasis Control and the Clinical Pathway on Advanced Schistosomiasis in Hubei Province the therapeutic effects disease awareness and the satisfaction of patients of 220 advanced schistosomiasis patients ascitic type who were treated by the traditional pathway in 2013 and 220 patients who treated by the clinical pathway in 2014 respectively were evaluated and compared with the statistical method. Results As the outcomes of the patients had no signifi?cant difference between the traditional pathway therapy and the clinical pathway therapy the average hospitalization days and medical expense were reduced when the patients were treated by the clinical pathway. The average hospitalization days were re?duced to 12 days from 14 days. The average medical expense was reduced to RMB 5 800 form RMB 6 400. The average rate of awareness about the disease and the satisfaction rate of the patients were raised to 95% in the patients treated by the clinical pathway. The results of t test for the three indicators above mentioned showed significant differences between the two therapies all P<0.05 . Conclusion The clinical pathway can standardize the medical behavior and avoid the waste of medical resourc?es so as to improve the treatment of advanced schistosomiasis.
